Literature DB >> 12224578

Progressive Chagas' cardiomyopathy is associated with low selenium levels.

Maria Teresa Rivera1, Andréa P de Souza, Alejandro Marcel Hasslocher-Moreno, Sergio S Xavier, Juliana A S Gomes, Manoel Otavio C Rocha, Rodrigo Correa-Oliveira, Jean Nève, Jean Vanderpas, Tania C Araújo-Jorge.   

Abstract

Selenium (Se) deficiency is linked with some cardiomyopathies. Its status was determined in 170 patients with chronic Chagas' disease from 2 Brazilian regions (Rio de Janeiro and Belo Horizonte), clinically stratified into groups as follows: indeterminate or asymptomatic (IND); cardiac asymptomatic (CARDa); cardiac symptomatic with moderate to severe heart dysfunction (CARDb); and healthy adults (HA), used for comparison. In most HA, Se levels were normal, excluding an overall Se deficiency. Se was significantly lower in CARDb than in HA, IND, or CARDa patients. This was not associated with a concomitant decrease in activity of glutathione peroxidase. Thyrotropin was normal, excluding iodine deficiency. Se correlated positive and significantly with ventricular ejection fraction (assessed via echocardiography). Asymptomatic children with acute Chagas' disease had normal Se as well as 5 noninfectious cases of cardiomyopathy. Low Se was found in 6 of 10 chagasic patients with digestive megasyndromes. Thus, the decrease in Se in chagasic patients seems to be a biological marker for Trypanosoma cruzi infection and related to the progression of pathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224578     DOI: 10.4269/ajtmh.2002.66.706

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  16 in total

1.  Leishmanicidal activities of novel methylseleno-imidocarbamates.

Authors:  Celia Fernández-Rubio; Daphne Campbell; Andrés Vacas; Elena Ibañez; Esther Moreno; Socorro Espuelas; Alfonso Calvo; Juan Antonio Palop; Daniel Plano; Carmen Sanmartin; Paul A Nguewa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

4.  Would selenium supplementation aid in therapy for Chagas disease?

Authors:  Linda A Jelicks; Andréa P de Souza; Tania C Araújo-Jorge; Herbert B Tanowitz
Journal:  Trends Parasitol       Date:  2011-01-04

5.  The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection.

Authors:  Andréa Pereira de Souza; Ryan Sieberg; Hua Li; Hannah R Cahill; Dazhi Zhao; Tania C Araújo-Jorge; Herbert B Tanowitz; Linda A Jelicks
Journal:  Parasitol Res       Date:  2010-02-27       Impact factor: 2.289

Review 6.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

7.  Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection.

Authors:  Andréa P de Souza; Gabriel Melo de Oliveira; Jean Vanderpas; Solange L de Castro; Maria Teresa Rivera; Tania C Araújo-Jorge
Journal:  Parasitol Res       Date:  2003-07-22       Impact factor: 2.289

Review 8.  Selenistasis: epistatic effects of selenium on cardiovascular phenotype.

Authors:  Jacob Joseph; Joseph Loscalzo
Journal:  Nutrients       Date:  2013-01-31       Impact factor: 5.717

9.  Nutritional Status Driving Infection by Trypanosoma cruzi: Lessons from Experimental Animals.

Authors:  Guilherme Malafaia; André Talvani
Journal:  J Trop Med       Date:  2011-04-14

Review 10.  Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Authors:  Maria-Jesus Pinazo; Maria-Carmen Thomas; Juan Bustamante; Igor Correia de Almeida; Manuel-Carlos Lopez; Joaquim Gascon
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.